Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine

Collaborate to Accelerate

What is MTIF?

A really big challenge in healthcare is getting innovations to patients quickly; it can take up to 17 years for a product to go from proof of concept to clinical use. MTIF aims to accelerate the development of innovative medtech products – including cell and gene therapies – that improve patient outcomes. As a partnership between two universities in Nottingham, UK, the NHS, investment groups, and industry networks, MTIF supports companies from “bench to bedside” in developing the next generation of medical technologies.

Why did you both decide to get involved?

Mike: I have spent my career developing new medicines and medical technologies that I hope have improved the lives of patients. Over 30 years ago, I was involved in developing treatments addressing the symptoms of AIDS; as science progressed, anti-retrovirals came along and we were able to treat AIDS as a chronic disease rather than a terminal one. We now understand the genetics associated with a number of diseases enabling the personalization of medicine and I was delighted to lead the pharmaceutical development of Lynparza as Vice President, Medicines Development at AstraZeneca. This scale of innovation is amazing – life changing – but it can also be protracted. And that led me to join the NHS and head up the Academic Health Science Network (AHSN), which is charged with accelerating the adoption of innovation within the NHS. The role involved discussions about MTIF with regional universities, hospitals, and government, and I recognized early on that MTIF was unique in approach, bringing together all the elements needed to enable quicker patient access to innovations. How could I not get involved?

John: With over three three decades of research and industrial experience developing and testing implanted medical devices and cellular therapies, I am very excited to be part of MTIF. This is a great opportunity to unlock invention and entrepreneurship, and accelerate innovations in the healthcare arena. By uniquely bringing academic and industrial expertise together within its auspices, MTIF will help enable the delivery of next generation therapies to meet the increasing demands made on healthcare.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!


Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.

From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine